Spore Bio Raises $23M for Microbiology Testing with AI

Spore.Bio has raised $23 million in a Series A round, following an €8 million pre-seed round last year. The round was led by Singular with support from previous investors.Dealroom has a profile for this one. Try Dealroom →

Spore.Bio is transforming microbiology testing with its AI-powered spectral analysis technology, delivering bacterial detection results in minutes instead of days. Traditional testing methods require offsite labs and long incubation times, but Spore.Bio’s on-site testing machines enable real-time food safety monitoring.

The company has secured contracts for 200 factories and opened a waitlist. Partnering with the Pasteur InstituteDealroom has a profile for this one. Try Dealroom →, Spore.Bio is expanding its technology into cosmetics and pharmaceuticals, where fast, reliable testing is essential. The company plans to grow its team from 30 to 50 by 2025.

Source: TechCrunch

B.O